Default Category
-
Novartis: el liderazgo de una empresa global
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-418S09StrategyNovartis, empresa de salud más importantes del mundo, se formó en 1996 de la fusión de dos compañías farmacéuticas muy diferente, de nivel medio con sede en Suiza. El caso describe la evolución de la compañía durante los últimos 17 años, ya que se transformó en una empresa verdaderamente global, con 127.000 empleados de 153 nacionalidades en 140 países y generando $ 56,7 mil millones en 2012 ingresos y $ 9.6 mil millones en ingresos netos, por lo...Starting at €8.20
-
Novartis: Leading a Global Enterprise
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-413096-ENovartis, the world's leading healthcare company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case traces the company's evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries generating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the firm one of the world's largest and mo...Starting at €8.20
-
Disrupting the Meat Industry: Tissue Culture Beef
Alvarez, Jose B.; Preble, MatthewCase HBS-515001-EMarketingDr. Mark Post and his team at Maastricht University were perfecting their tissue culture beef product-made entirely from muscle grown in his lab-to give it the same taste, texture and appearance of a traditional beef hamburger. A previous iteration of this product had been taste tested live, with good results, and Sergey Brin, a co-founder of Google, had provided Post with much of the funding to make the burgers. The next step was to form an inde...Starting at €8.20
-
The "Wonder Drug" that Killed Babies
Krieger, Joshua Lev; Nicholas, Tom; Preble, MatthewCase HBS-818044-EEconomicsIn the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children may have been affected. Just a handful of these children were born in the U.S., where safety concerns were raised by Dr. Frances Oldham Kelsey, the medical officer handling the thali...Starting at €8.20